GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » Debt-to-EBITDA

Peijia Medical (HKSE:09996) Debt-to-EBITDA : -0.44 (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Peijia Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$3.1 Mil. Peijia Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$202.4 Mil. Peijia Medical's annualized EBITDA for the quarter that ended in Jun. 2023 was HK$-462.3 Mil. Peijia Medical's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was -0.44.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Peijia Medical's Debt-to-EBITDA or its related term are showing as below:

HKSE:09996' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.57   Med: -0.01   Max: 0
Current: -0.57

HKSE:09996's Debt-to-EBITDA is ranked worse than
100% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs HKSE:09996: -0.57

Peijia Medical Debt-to-EBITDA Historical Data

The historical data trend for Peijia Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical Debt-to-EBITDA Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.01 - -0.01 -0.37 -0.57

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.01 -0.38 -0.22 -0.44 -0.61

Competitive Comparison of Peijia Medical's Debt-to-EBITDA

For the Medical Devices subindustry, Peijia Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peijia Medical's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Peijia Medical's Debt-to-EBITDA falls into.



Peijia Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Peijia Medical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(65.834 + 81.433) / -401.911
=-0.37

Peijia Medical's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.099 + 202.395) / -462.324
=-0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2023) EBITDA data.


Peijia Medical  (HKSE:09996) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Peijia Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Peijia Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Peijia Medical (HKSE:09996) Business Description

Traded in Other Exchanges
N/A
Address
8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.
Executives
Jinnius Drive Trust 2103 Interests held jointly with another person
Xinyue International Limited 2103 Interests held jointly with another person
Ye Hong 2103 Interests held jointly with another person
Zhang Ping Ye 2103 Interests held jointly with another person
Zhang Yi 2301 Trustee
Hanlindale Trust 2103 Interests held jointly with another person
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hh Imv Holdings, L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Shi Yi 2201 Interest of corporation controlled by you

Peijia Medical (HKSE:09996) Headlines

No Headlines